PANDA Revisited: Sertraline’s Early Benefit Missed
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A study known as PANDA has been reexamined, focusing on the medication sertraline. The reexamination suggests that an early benefit of sertraline may have been overlooked. The findings indicate a potential missed advantage of the medication.